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Ornithine-derived polyamines are essential for cell proliferation, and their levels are 
elevated in many human tumors. Neuroblastoma, the most frequent extra-cranial solid 
tumor in children, harbors amplification of n-myc oncogene (which enhances polyamine 
metabolism) in 25% of the cases. In the present communication, the relevance of n-myc 
amplification in several metabolic features of human neuroblastoma cell lines is studied. 
A previously unknown linkage between glycolysis impairment and polyamine 
reduction, related to n-myc amplification, is unveiled. Results show that glycolysis 
inhibition is able to trigger signaling events leading to the reduction of N-Myc protein 
levels and subsequent decrease of both ornithine decarboxylase expression and 
polyamine levels, accompanied by cell cycle blockade preceding cell death. 
Metabolism-targeted therapies are emerging as new approaches for cancer treatment. 
New anti-tumor strategies could take advantage of the direct relationship between 
glucose deprivation and PA metabolism impairment leading to cell death described in 
the present work, and its apparent dependence on n-myc amplification in the case of 
neuroblastoma. Combined therapies targeting glucose metabolism and polyamine 
synthesis could be effective in the treatment of n-myc amplified tumors.
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